Calpastatin is regulated by protein never in mitosis gene A interacting-1 (PIN1) in endothelial cells

Tongzheng Liu1, Ryan A Schneider, Dale G Hoyt

  • 1Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA. liu.tongzheng@mayo.edu

Insights

Protein never in mitosis gene A interacting-1 (PIN1) restrains calpastatin, an inhibitor of calpains. PIN1 depletion enhances calpastatin activity, lowering calpain activity in endothelial cells.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Protein never in mitosis gene A interacting-1 (PIN1) isomerizes phosphorylated serine/threonine-proline motifs.
  • PIN1 depletion previously increased cyclooxygenase-2 and inducible nitric oxide synthase by lowering calpain activity in murine aortic endothelial cells (MAEC).
  • The role of PIN1 in regulating calpastatin, the endogenous inhibitor of μ- and m-calpains, was investigated.

Purpose of the Study:

  • To investigate the effect of PIN1 on calpastatin's inhibitory activity towards calpains.
  • To determine the mechanism by which PIN1 influences calpain activity in MAEC.

Main Methods:

  • Murine aortic endothelial cells (MAEC) were transduced with small hairpin RNA (shRNA) to knock down PIN1 (KD) or control shRNA.
  • Cells were treated with non-targeted or calpastatin-depleting small interfering RNA (siRNA).
  • Calpastatin co-immunoprecipitation with PIN1 and GST-PIN1 fusion protein pull-down assays were performed.

Main Results:

  • PIN1 KD increased calpastatin inhibitory activity without altering calpastatin or calpain expression levels.
  • PIN1 directly interacts with calpastatin, and this interaction requires PIN1's protein interaction and isomerase functions.
  • Calpastatin depletion abolished the effect of PIN1 KD on calpain activity, indicating calpastatin is essential for PIN1's regulation of calpains.

Conclusions:

  • PIN1 restrains calpastatin's inhibition of calpains, thereby maintaining calpain activity in endothelial cells.
  • PIN1 may directly target phosphorylated serine/threonine-proline motifs in calpastatin or indirectly regulate it via other substrates.
  • This study reveals a novel regulatory role for PIN1 in the calpain pathway, with implications for endothelial cell function.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...